Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for low back pain in osteoporosis with lumbar disc degeneration
ChiCTR1800018620Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of teriparatide in lumbodynia (LBP), degenerative disc disease (DDD) and osteopenia (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: MRI. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
teriparatide
03
Conditions
lumbodynia (LBP)degenerative disc disease (DDD)osteopenia
Beyond the preview
Go deeper on ChiCTR1800018620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018620.